21st Century Cures Act supporters crush meager House opposition, head to a final showdown in the Senate
Critics of the 21st Century Cures Act in the House didn’t have a prayer in their fight against the bill. In a rare show of bipartisan support that will likely prove hard to stare down in the Senate, Democrats and Republicans in the lame-duck session voted in favor of the revised legislation by a vote of 392 to 26.
Supporters called it a win-win for patients and biopharma, promising to speed drugs even faster through the regulatory process while funneling billions to support new research initiatives like the cancer moonshot, spearheaded by outgoing vice president Joe Biden.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
